Rankings
▼
Calendar
CRBU Q2 2023 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
CRBU
Caribou Biosciences, Inc.
$186M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
-10.4% YoY
Gross Profit
-$23M
-605.8% margin
Operating Income
-$33M
-875.3% margin
Net Income
-$30M
-786.1% margin
EPS (Diluted)
$-0.48
QoQ Revenue Growth
+7.2%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$18M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$350M
Total Liabilities
$80M
Stockholders' Equity
$269M
Cash & Equivalents
$66M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$4M
-10.4%
Gross Profit
-$23M
-$18M
-23.7%
Operating Income
-$33M
-$28M
-15.6%
Net Income
-$30M
-$27M
-10.6%
Geographic Segments
UNITED STATES
$4M
100%
Non-US
$9,000
0%
← FY 2023
All Quarters
Q3 2023 →